A Renal DTPA (Diethylenetriaminepentaacetic acid) scan is a dynamic nuclear medicine imaging procedure used to evaluate kidney function
A Renal EC (Technetium-99m Ethylenedicysteine) scan is a dynamic nuclear medicine imaging procedure used to evaluate kidney function, blood flow, and drainage. Unlike DTPA, which is cleared by glomerular filtration, Tc-99m EC is primarily excreted via tubular secretion. This mechanism provides a high extraction fraction and excellent target-to-background image contrast, making it especially useful for pediatric patients and those with significantly impaired renal function. Acquired on a Gamma Camera, the scan precisely calculates Effective Renal Plasma Flow (ERPF). It is highly effective for diagnosing obstructive uropathy, evaluating renal transplants, and assessing renovascular hypertension, serving as a robust alternative to MAG3.
A Technetium-99m pertechnetate thyroid scan is a nuclear imaging procedure that evaluates thyroid anatomy and function. Acquired on a Gamma Camera, it maps radiotracer trapping to diagnose hyperthyroidism, locate ectopic tissue, and distinguish functional "hot" nodules from potentially malignant "cold" nodules, providing rapid results with excellent diagnostic image contrast.
A Technetium-99m bone scan uses radiotracers like Tc-99m MDP to map osteoblastic activity. Acquired on a Gamma Camera, it is highly sensitive for detecting skeletal metastases, occult fractures, and osteomyelit
A Technetium-99m DMSA scan is a static nuclear imaging procedure evaluating the renal cortex. Acquired on a Gamma Camera, it detects cortical scarring, pyelonephritis, and accurately calculates differential renal function.
A 99mTc-sestamibi parathyroid scan uses a radiotracer to detect hyperfunctioning adenomas. Utilizing dual-phase imaging on a Gamma Camera or SPECT-CT, it accurately localizes abnormal glands to guide targeted surgical excision.
A Whole Body I-131 Scan uses radioactive iodine to detect remnant tissue or metastases in patients with differentiated thyroid cancer following a thyroidectomy. It guides targeted therapy and monitors efficacy.
An FDG cardiac viability PET scan evaluates myocardial glucose metabolism. It distinguishes hibernating myocardium from irreversible scar tissue, accurately identifying patients who will benefit from surgical revascularization procedures.